Virtu Financial LLC Surrozen, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.89 $5,347 - $10,817	12,154 New	12,154 $6,000
Q1 2023 May 01, 2023	BUY	$0.56 - $1.32 $13,714 - $32,326	24,490 Added 226.21%	35,316 $21,000
Q4 2022 Feb 15, 2023	BUY	$0.42 - $41.25 $4,546 - $446,572	10,826 New	10,826 $6,000
Q4 2021 Feb 17, 2022	SELL	$6.0 - $9.92 $134,772 - $222,823	-22,462 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.98 - $12.03 $156,784 - $270,217	22,462 New	22,462 $159,000

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $371M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.